Labeled use of allopurinol

  • PTCB PTCE
  • Medications
  • Multiple choice
  • Difficulty 2 of 5

Question

A rheumatology clinic's standing orders for gout include a drug that lowers uric acid production to keep attacks from coming back. Which drug fits that description?

  1. Alendronate✗ Incorrect

    Alendronate is a bisphosphonate labeled for osteoporosis and Paget's disease of bone.

  2. Hydroxychloroquine✗ Incorrect

    Hydroxychloroquine treats malaria and certain rheumatic diseases; allopurinol is the xanthine oxidase inhibitor used for gout management.

  3. Methocarbamol✗ Incorrect

    Methocarbamol is used with rest and therapy for painful musculoskeletal conditions; allopurinol is labeled for gout management.

  4. Allopurinol✓ Correct

    Correct. Allopurinol inhibits xanthine oxidase to reduce uric acid formation and is labeled for managing gout.

Answer

D. Allopurinol

Rationale

Allopurinol inhibits xanthine oxidase, reducing uric acid formation, and is labeled for gout management. Colchicine is used both to treat and to prevent gout flares. Alendronate is labeled for osteoporosis, hydroxychloroquine for malaria and certain rheumatic diseases, and methocarbamol for painful musculoskeletal conditions.

RememberAllopurinol reduces uric acid formation; colchicine can treat and prevent gout flares.

Sources

Sources marked “Adapted from” are licensed under CC BY 4.0. We changed the material: its facts are rewritten into an original question, answer options and rationale. The original authors and publishers do not endorse SwipeExam.

Last verified: 2 independent automated checks Question ptcb-m-00025, version 1

Checks are automated. No licensed clinician has reviewed this question. Check the sources and your program’s materials.

Report an error in this question. For education only; not medical advice. See all sources and licenses.

More PTCB PTCE sample questions